tiprankstipranks
X4 Pharmaceuticals Inc (XFOR)
NASDAQ:XFOR
US Market
XFOR
X4 Pharmaceuticals
RESEARCH TOOLSreports
Want to see XFOR full AI Analyst Report?

X4 Pharmaceuticals (XFOR) Financial Statements

1,114 Followers

X4 Pharmaceuticals Financial Overview

X4 Pharmaceuticals's market cap is currently $372.77M. The company's EPS TTM is $; its P/E ratio is -2.14; X4 Pharmaceuticals is scheduled to report earnings on April 30, 2026, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 35.11M$ 2.56M$ 0.00$ 0.00$ 0.00
Gross Profit$ 28.86M$ 1.76M$ 0.00$ 0.00$ -1.89M
Operating Income$ -86.88M$ -36.40M$ -107.52M$ -87.57M$ -75.35M
EBITDA$ -85.61M$ -27.58M$ -94.89M$ -89.33M$ -73.46M
Net Income$ -79.20M$ -37.45M$ -101.17M$ -93.87M$ -88.70M
Balance Sheet
Cash & Short-Term Investments$ 253.00M$ 102.06M$ 114.22M$ 121.72M$ 81.79M
Total Assets$ 290.46M$ 146.45M$ 147.26M$ 155.59M$ 117.18M
Total Debt$ 77.28M$ 78.09M$ 58.28M$ 38.42M$ 39.78M
Net Debt$ -139.76M$ 22.39M$ -40.94M$ -83.30M$ -42.00M
Total Liabilities$ 104.17M$ 124.30M$ 96.16M$ 81.53M$ 52.76M
Stockholders' Equity$ 186.29M$ 22.15M$ 51.10M$ 74.05M$ 64.41M
Cash Flow
Free Cash Flow$ -88.62M$ -138.23M$ -96.57M$ -77.20M$ -71.52M
Operating Cash Flow$ -85.62M$ -130.90M$ -96.51M$ -77.10M$ -70.91M
Investing Cash Flow$ 8.15M$ 66.99M$ -14.88M$ -103.00K$ -615.00K
Financing Cash Flow$ 238.63M$ 20.29M$ 88.52M$ 117.23M$ 74.25M
Currency in USD

X4 Pharmaceuticals Earnings and Revenue History

Income Statement >

X4 Pharmaceuticals Debt to Assets

Balance Sheet >

X4 Pharmaceuticals Cash Flow

Cash Flow >

X4 Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >